Objective To present results from the UK NHS breast screening programme (NHSBSP) for the six-year period from 1 April 1999 to 31 March 2005, and to compare these with targets. Methods Data are collected annually from all UK screening units on standard KC62 return forms.
INTRODUCTION
T he UK National Health Service Breast Screening Programme (NHSBSP) was introduced in 1988 following the recommendation of the Forrest committee, and women aged between 50 and 64 years were invited to screening at three yearly intervals. 1 While the Forrest report recommended that single-view mammography be used and that a single radiologist or other medically qualified individual should read the mammogram, in practice a number of units used two-view mammography from the beginning and some chose to double read mammograms.
Results from the programme for the periods 1990-93 and 1994-99 have been published in two earlier papers. 2, 3 Targets for interim outcome measures have been defined by the programme. Results from the first period showed that, while uptake was good and the majority of targets were being met, the detection of small (p10 mm) invasive cancers was lower than the target. The overall prevalence of screen-positive cancer (cancer detection rate) was influenced by the higher than expected detection of in situ cancers and the crude rates suggested that an estimate of sensitivity was misleadingly optimistic. By the later period, uptake had remained constant while invasive cancer detection rates had improved with the standardized detection ratio (SDR) 4 reaching 1 or more in the years after 1996. This indicates that the NHSBSP was detecting an equivalent invasive cancer detection rate to the Swedish Two-County Study randomized controlled trial which is used by the NHSBSP as a performance yardstick. Furthermore, data quality had improved although detailed longitudinal comparisons remained difficult due to changes in the annual statistical returns.
Since its introduction, the NHSBSP has continually looked for ways to improve its performance. An observational study in 1994 suggested that units with film density lower than 1.2D detected fewer small (p10 mm) invasive cancers than units with film density more than 1.2D. 5 This led to the introduction of a target film density of 1.4-1.8D.
Further, the results of a randomized controlled trial showed that two-view mammography improved cancer detection rates by 24% in comparison with single-view mammography, while reducing recall rates by 15%. 6 An observational study of units using two-view mammography supported these results and a further evaluation of units moving from single-view to two-view mammography at the prevalent screen showed a 45% increase in the detection of invasive cancers less than 15 mm. 7, 8 A further observational study by Young et al. 9 showed than the combined effect of two-view mammography (at both screens) and film density more than or equal to 1.4D was that 25% more invasive cancers were detected than using single-view mammography with film densities below 1.4D. Most of these studies related to prevalent screens as the programme only achieved full coverage in 1995. This, in addition to the fact that only 50% of units had used two-view mammography for prevalent screens and the workload was beginning to increase, meant that two-view mammography was introduced as policy at the first screen in August 1995. 10 In 2000, the NHS Cancer Plan for England announced the introduction of two-view mammography at the incident screen along with the inclusion of women aged 65-70 years into the routine invitation system. 11 This expansion was supported by evidence from further studies. Given-Wilson et al. showed the benefit of a second view applied to the incident screen as well as the prevalent screen and Hackshaw et al. provided further evidence that it was in the detection of small invasive cancers that two views was most beneficial. 12, 13 Evidence from demonstration sites also supported the extension of the upper age of invitation to 70 years. 14 All units in England were expected to have commenced two-view mammography at both screens by 2003 and the majority of units did so in the two-year period between 1 April 2001 and 31 March 2003. Results from these units showed that the introduction of two-view mammography produced a 20% increase in incident cancer detection rates with an 11% decrease in recall rates. 15 Units in Northern Ireland used two-view mammography at both screens from the beginning, while units in Wales introduced two views at the incident screen in 2001, having used it at the first screen from the outset. Scotland has recently announced its plan to introduce two-view mammography at both screens by 2010.
At the same time as this expansion was announced, the absolute number of women aged between 50 and 64 years who were eligible for invitation to screening increased as a result of the 'post war baby boom'. Furthermore, there was a national shortage of radiological staff. 16 Consequently, the NHS Cancer Plan for England also announced the introduction of the four-tier workforce structure to help address these workforce shortages alongside recruitment initiatives. The four-tier workforce has seen assistant practitioners taking mammograms, thus allowing radiographers to undertake more advanced tasks historically performed by clinicians, such as reading mammograms, performing ultrasounds and undertaking investigative procedures.
English units were also expected to have begun inviting women aged 65- 
METHODS
The statutory KC62 return records activity and outcome data in the NHSBSP, and is generated annually by individual screening units. For example, data for the year 2005 represent the cohort of women invited to screening between 1 April 2004 and 31 March 2005. In the past, substantial revisions to the return have made longitudinal comparisons difficult. The most recent revision saw the return refined rather than undergoing any major changes. There were two main amendments. Firstly, the age bands were altered. The 50-54 years age band was split into two 50-52 and 53-54 years age bands, permitting more detailed analysis of the 'post war baby boom' and easier identification of the cohorts of women being invited for the first and subsequent time, and the older age bands were expanded, which will allow a comprehensive evaluation of the extension of the upper age of invitation from 64 to 70 years to be undertaken. Secondly, an annex was added to the return, providing anonymized individual-based histological information for each of the cancers detected by the programme.
Units submitted data on the revised KC62 for 2003 onwards. Consequently, for comparability, data presented in this paper for 2000-2005 are for the 50-54, 55-59 and 60-64 years age groups. Results are presented for the first invitation to routine screening for women aged 50-54 years, although most women are invited between 50 and 52 years. Incident screens relate to women, aged 50-64 years, returning to screening for a second or subsequent time; most women being aged between 53 and 64 years.
The same performance measures as those presented in earlier papers for the years between 1990 and 1999, such as uptake, recall to assessment and cancer detection rates, are considered in this paper. Although data are available on invasive cancers less than 15 mm, we present data for invasive cancers less than 10 mm to allow comparability with the earlier papers.
Invasive cancer detection rates are presented using the SDR. 4 The performance of individual programmes, for both prevalent and incident screens combined, is shown graphically using positive predictive value (PPV)-referral diagrams for the years 2000 and 2005 separately. The diagrams were first published in 2001 and are a graphical technique produced to illustrate individual programme performance. 17 They plot PPV of recall against recall to assessment rate with cancer detection rate expressed as isobars on the graph.
Performance is compared with NHSBSP targets that were revised in 2003. 18 Non-operative diagnosis figures exclude Scotland, as therapeutic as well as diagnostic biopsies are included and are therefore not comparable.
RESULTS

Rates of uptake and recall to assessment
Uptake rates have remained stable over the six years at, on average, 75% at the first invitation to screening for women aged 50-54 years and 89% for subsequent invitations to previous attenders aged 50-64 years ( Tables 1 and 2) . Overall uptake in 2005, for all invitations (including previous non-responders) was 75.1%; for individual units, uptake at first invitation ranged from 49.6% to 84.9% for women aged 50-54 years, and from 72.9% to 93.2% for subsequent invitations for women aged 50-64 years.
Average rates of recall to assessment for the six-year period were 8.6% for women aged 50-54 years at their first invitation to screening and 3.8% for women aged 50-64 years at their subsequent invitation to screening (Tables 1  and 2 ). In 2005, 52% of units met the minimum standard of less than 10% of women screened being recalled to assessment at prevalent screen with a further 26% of units meeting the target of less than 7%. At the incident screen, all units met the minimum standard of less than 7% and 92% of units also met the target of less than 5%.
Cancer detection rates
Cancer detection rates and PPVs, at both screens, have increased during the six-year period ( Tables 1 and 2 ). In particular, cancer detection rates have increased by 24% at the incident screen, from 5.4 per 1000 in 2000 to 6.7 per 1000 in 2005. The PPV has increased from 14.2% to 18.8% at the incident screen; from one in seven women recalled for assessment receiving a diagnosis of cancer to approximately one in five. Cancer detection rates at the prevalent screen have increased by 14%, from 6. (a) (b) Figure 1 (a) PPV versus recall to assessment rate with cancer detection isobars, women aged 50-64 years. (b) PPV versus recall to assessment rate with cancer detection isobars, women aged 50-64 years Table 5 shows SDRs for the prevalent and incident screen separately and combined for the six-year period for women aged 50-64 years. At the prevalent screen, there has been an 8% increase in SDR, from 1.26 in 2000 to 1.41 in 2005. At the incident screen, there has been a 23% increase in SDR from 1.10 in 2000 to 1.35 in 2005. 
Non-operative diagnosis
DISCUSSION
These results show that the programme is performing well against the targets. Further standardization of the programme has occurred with the introduction of two views at the incident screen, and while the 24% increase in cancer detection between 2000 and 2005 is in line with that of earlier studies, the 6% decrease in recall rates was not as great as the 15% shown by Wald et al. 6 Variations at the unit level, in particular recall rates, still remain and the reasons for this are an area for potential investigation. The extra workload at assessment for units recalling a high proportion of women will add to the other pressures already faced by the programme.
The SDR suggests that the programme is now detecting substantially more cancers, after adjusting for background incidence, than the Swedish Two-County Study. However, while the SDR does reflect improvements in performance, it may also reflect an increase in underlying incidence since the estimates of background incidence used in the development of the SDR, as well as round length slippage (where women are screened more than 3 years since their last screen). However, the impact of round length slippage is considered to be small. 15 A significant part of the increase in underlying incidence is the result of an increased use of hormone replacement therapy (HRT). 19 It has been estimated that the SDR could be inflated by 11% (Waller M, personal communication). This would mean that after allowing for increases in background incidence, the overall SDR for 2005 would be 1.23; still well in excess of the target of 1. However, if women now tend to stop taking HRT, we would expect a decrease in underlying incidence and thus the SDR. Such a trend in incidence has recently been reported in the USA. 20 The increase in the sensitivity of the programme should result in a reduction in rates of interval cancers as well as an increase in the rates of detection of screen-detected cancers. Regional interval cancer rates in early publications for the North West and East Anglia regions were higher than expected and were believed to be as a result of poor sensitivity for small cancers. 21, 22 At the time of their publication, data on interval cancers were not available at a national level. Since 2000, significant progress has been made by the Cancer Screening Evaluation Unit in collating individual-based data on interval cancers in collaboration with cancer registries and the NHSBSP in England, Wales and Northern Ireland. Analyses of these data in the future will enable the rates of interval cancers in women screened between 2000 and 2005 to be compared with the SDR over the same period, and will help determine if the increase in SDR is a true increase in the sensitivity of the programme or reflection of the increase in underlying incidence. With all units in England, Wales and Northern Ireland now using two-view mammography, and more units now inviting women aged between 65 and 70 years, the pressure on the programme continues with many units failing to meet the target of 90% of women being offered an appointment within 36 months of their last routine screen (manuscript in preparation). The extent to which the new ways of working will address this is important. A workforce survey conducted by the programme in 2004 reported that the number of advanced practitioners had increased, while vacancies for radiologists had decreased. 23 In addition, the expanding role of the advanced practitioner will help ease the strain. While the reading policy has not changed since the inception of the programme, most units do double read mammograms, many using a radiographer as the second reader. Experimental evidence has shown that, after adjusting for reading volume and experience, radiographers read as well as radiologists. 24 Consequently, to gain evidence in a real-life setting, a number of pilot units are currently using only radiographers to read mammograms, with any discordant opinions being arbitrated by a clinician. Results from this study, along with those looking at technologies associated with digital mammography such as the use of computer-aided detection systems, will help inform how screening for breast cancer in the UK can be delivered in the future. 
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